SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-09-020005
Filing Date
2009-04-10
Accepted
2009-04-10 14:16:02
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v145678_10qa.htm 10-Q/A 1591440
2 v145678_ex31-1.htm EX-31.1 9422
3 v145678_ex31-2.htm EX-31.2 9361
4 v145678_ex32-1.htm EX-32.1 6912
  Complete submission text file 0001144204-09-020005.txt   1618925
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-53037 | Film No.: 09744924
SIC: 2834 Pharmaceutical Preparations